05.03.2013                      23.Adar. 5773

Medizin:

Teva's progesterone ring passes Phase III clinical test

Study finds vaginal ring used weekly to supplement progesterone of in vitro fertilization patients is equally effective in getting them pregnant as daily vaginal gel.

A vaginal ring used once a week to supplement the progesterone of women undergoing in vitro fertilization is as effective in getting them pregnant as a vaginal gel that must be applied every day, according to the results of the Phase III clinical trial for the Milprosa vaginal ring, Milprosa manufacturer Teva Pharmaceutical Industries announced Monday….